KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $40.4 million.

  • Vir Biotechnology's Cash from Investing Activities fell 6589.8% to $40.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $364.5 million, marking a year-over-year increase of 4358.93%. This contributed to the annual value of $499.4 million for FY2024, which is 20332.87% up from last year.
  • According to the latest figures from Q3 2025, Vir Biotechnology's Cash from Investing Activities is $40.4 million, which was down 6589.8% from $56.5 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Cash from Investing Activities ranged from a high of $230.3 million in Q2 2023 and a low of -$662.6 million during Q3 2022
  • Over the past 5 years, Vir Biotechnology's median Cash from Investing Activities value was $56.5 million (recorded in 2025), while the average stood at -$23.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 61209.26% in 2021, then plummeted by 99712.15% in 2022.
  • Over the past 5 years, Vir Biotechnology's Cash from Investing Activities (Quarter) stood at -$377.6 million in 2021, then surged by 59.44% to -$153.1 million in 2022, then soared by 31.56% to -$104.8 million in 2023, then soared by 234.28% to $140.7 million in 2024, then plummeted by 71.26% to $40.4 million in 2025.
  • Its Cash from Investing Activities stands at $40.4 million for Q3 2025, versus $56.5 million for Q2 2025 and $126.8 million for Q1 2025.